Home/ Supplements/ Alpha Lipoic Acid/ Total Alpha Lipoic Acid

Total Alpha Lipoic Acid

product on market Tablet or Pill Nutri-West Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Alpha lipoic acid and B-complex vitamins are supported by moderate to strong evidence for supporting metabolic function and nerve health. These ingredients work synergistically to facilitate energy production and antioxidant activity within cells. The formulation maintains a high safety profile based on available clinical data.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Total Alpha Lipoic Acid
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
5 mg (333% DV)
4.2× RDA — above typical dose 76 studies (A:0, B:33)
5 mg (294% DV)
3.8× RDA — above typical dose 13 studies (A:0, B:1)
10 mg (500% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
5 mg (25% DV)
Within RDA (0.4× RDA) 196 studies (A:5, B:63)
5 mg (50% DV)
Within RDA (1.0× RDA) 2 studies — no high-quality reviews
10 mg (2.5% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
3 mg (20% DV)
Within RDA (0.3× RDA) 263 studies (A:6, B:134)
25 mcg (33% DV)
Within RDA (0.6× RDA) 3 studies — no high-quality reviews
5 mcg (72% DV)
Within RDA (0.1× RDA) 173 studies (A:0, B:67)
1 mg (50% DV)
Within RDA (0.4× RDA) 9 studies — no high-quality reviews
1.7× RDA — within safe limits 76 studies (A:0, B:33)
3.8× RDA — above typical dose 13 studies (A:0, B:1)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
20 mg
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions for use: One tablet daily or as directed.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

TAMPER RESISTANT OUTER SEAL - DO NOT USE IF BROKEN.

Formulation Notes

Contains no starch, salt, sugar, milk, wheat, corn, yeast, soy or preservatives.

Additional Information

Manufactured under strict GMP and USP guidelines.

"When You Want The Best"

9526 MFG10/2009

Store in cool, dry place.

FOR DISTRIBUTION BY HEALTH CARE PROFESSIONALS ONLY

Product # 2725

Metadata

Product Details

DSLD Entry Date2013-12-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID28291
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.